2021
DOI: 10.3390/ijms22168502
|View full text |Cite
|
Sign up to set email alerts
|

TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation

Abstract: The transient receptor potential melastatin subtype 8 (TRPM8) is a cold sensor in humans, activated by low temperatures (>10, <28 °C), but also a polymodal ion channel, stimulated by voltage, pressure, cooling compounds (menthol, icilin), and hyperosmolarity. An increased number of experimental results indicate the implication of TRPM8 channels in cold thermal transduction and pain detection, transmission, and maintenance in different tissues and organs. These channels also have a repercussion on differe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(15 citation statements)
references
References 165 publications
0
15
0
Order By: Relevance
“…TRPM8 is involved in the abnormal bladder sensation, and its potential as an attractive molecular target in the lower urinary tract has been assessed 4–7 . Recently, several TRPM8 antagonists have been reported, and inhibition of TRPM8 would be a promising therapeutic option for hypersensitive bladder disorders 8–13 …”
Section: Introductionmentioning
confidence: 99%
“…TRPM8 is involved in the abnormal bladder sensation, and its potential as an attractive molecular target in the lower urinary tract has been assessed 4–7 . Recently, several TRPM8 antagonists have been reported, and inhibition of TRPM8 would be a promising therapeutic option for hypersensitive bladder disorders 8–13 …”
Section: Introductionmentioning
confidence: 99%
“…Its cytoplasmatic region comprises the C-terminal and D-terminal domains. The latter includes four melastatin zones [ 78 ]. The TRPA1 channel is another cold sensor.…”
Section: Structurementioning
confidence: 99%
“…In addition, the expression of the same mSR in different but strictly connected tissues in the TME also offers the possibility to intervene not only on the tumorigenic process itself but also in cancer-sustaining mechanisms. Synthetic and natural compounds able to bind mSRs here presented-apart from TRPM8 and GPER, whose molecular modulators were recently and excellently reviewed [203,204]-are listed in Table 1. PaCa-2 cells (pancreatic cancer) RACK1, alpha-Actinin-1 Reduced PGRMC1 interactions with the actin cytoskeleton [225] Human granulosa/luteal cell B-cell lymphoma 2 (BCL2) pathway Increased PGRMC1 monomeric form, increased proapoptotic Harakiri (Hrk) expression [226] Due to the relative novelty of mSRs as mediators of steroid signaling, studies on mSRactive compounds here presented were limited to the pre-clinical phase.…”
Section: Msrs As Drug Targetsmentioning
confidence: 99%
“…In addition, the expression of the same mSR in different but strictly connected tissues in the TME also offers the possibility to intervene not only on the tumorigenic process itself but also in cancer-sustaining mechanisms. Synthetic and natural compounds able to bind mSRs here presented—apart from TRPM8 and GPER, whose molecular modulators were recently and excellently reviewed [ 203 , 204 ]—are listed in Table 1 .…”
Section: Beyond Msrs Physiologic Rolementioning
confidence: 99%